Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Maxcyte (MXCT) Interest Expenses (2020 - 2022)

Historic Interest Expenses for Maxcyte (MXCT) over the last 3 years, with Q4 2022 value amounting to $11000.0.

  • Maxcyte's Interest Expenses changed N/A to $11000.0 in Q4 2022 from the same period last year, while for Sep 2023 it was $11000.0, marking a year-over-year decrease of 9051.72%. This contributed to the annual value of $127000.0 for FY2022, which is 8783.99% down from last year.
  • Latest data reveals that Maxcyte reported Interest Expenses of $11000.0 as of Q4 2022.
  • Maxcyte's 5-year Interest Expenses high stood at $742300.0 for Q1 2021, and its period low was $11000.0 during Q4 2022.
  • For the 3-year period, Maxcyte's Interest Expenses averaged around $235000.0, with its median value being $213950.0 (2020).
  • The largest annual percentage gain for Maxcyte's Interest Expenses in the last 5 years was 980.24% (2021), contrasted with its biggest fall of 9198.54% (2021).
  • Quarter analysis of 3 years shows Maxcyte's Interest Expenses stood at $280600.0 in 2020, then rose by 2.99% to $289000.0 in 2021, then plummeted by 96.19% to $11000.0 in 2022.
  • Its Interest Expenses stands at $11000.0 for Q4 2022, versus $116000.0 for Q3 2022 and $289000.0 for Q3 2021.